ANRS, Emerging Infectious Diseases: COVID-19 trials

The registry lists 13 COVID-19 studies with ANRS, Emerging Infectious Diseases as lead sponsor. 3 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 7Phase 3 2No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study Comparing Safety and Immunogenicity of Intranasal COVID-19 Vaccine and mRNA Booster in Healthy AdultsRecruitingNCT06821126Phase 1/2
• Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.RecruitingNCT06255626Phase 1/2
• OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy TrialRecruitingNCT05587894Phase 2
• Measure of Vaccine Effectiveness to Prevent Hospitalizations for Viral Respiratory Infections in AdultsStatus unknownNCT05582239
• Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in GuineaActive, not recruitingNCT05409300Phase 2
• Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 VaccineActive, not recruitingNCT05409261Phase 2
• Variants of SARS-CoV-2 Causing COVID-19 in AfricaCompletedNCT05311891
• Pre-exposure Prophylaxis of SARS-CoV-2 Infection (COVID-19) by Monoclonal Antibodies with Early Access Authorization in Immunocompromised Patients. a Prospective Cohort.CompletedNCT05216588
• Prevention of Mental Health Problems Among Persons Without Personal Housing in the Context of the COVID-19 EpidemicStatus unknownNCT05033210Not applicable
• Early Treatment of Vulnerable Individuals With Non-Severe SARS-CoV-2 InfectionStatus unknownNCT04920838Phase 2/3
• Prevention of COVID-19 Complications in High-risk Subjects Infected by SARS-CoV-2 and Eligible for Treatment Under a Cohort ATU ('Autorisation Temporaire d'Utilisation') OR or Authorisation for Early Access (AAP). A Prospectvie Cohort.CompletedNCT04885452
• Epidemiological Investigation of COVID-19 in Laos Using a One-Health Approach in Human and AnimalsStatus unknownNCT04716543
• Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb TrialCompletedNCT04466241Phase 2/3